Grifols SA (GIKLY) community

GIKLYOTCPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GRFS

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 17, 2026Score 9/30

$5.55+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.91BP/E 4.2Yield –

Community

Notes and questions about Grifols from other investors

No posts about GIKLY yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Grifols's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jan 4, 2016
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GIKLY.

Compare: GIKLY vs OGN · GIKLY vs TEVA · GIKLY vs VTRS · GIKLY vs ONC · GIKLY vs BHC

Revenue growth4.3% · median 4.4%

Gross margin38.0% · median 58.8%

Operating margin16.5% · median 11.3%

Net margin5.3% · median 4.2%

Company	Revenue	Growth
VTRS	$14.74B	+4.4%
TEVA	$14.10B	-15.2%
BHC	$11.11B	+10.8%
GIKLY	€7.52B	+4.3%
ONC	$6.13B	+34.3%
OGN	$6.10B	-3.2%

Company

Exchange: OTC
Industry: Pharmaceutical Preparations
Employees: 1,613
Auditor: KPMG Auditores, S.L.
SEC CIK: 1438569

Advertisement
300 × 250

See a number that looks wrong?